1
|
Norton-Gregory AA, Kulkarni NM, O'Connor SD, Budovec JJ, Zorn AP, Desouches SL. CT Esophagography for Evaluation of Esophageal Perforation. Radiographics 2021; 41:447-461. [PMID: 33577418 DOI: 10.1148/rg.2021200132] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Esophageal emergencies such as rupture or postoperative leak are uncommon but may be life threatening when they occur. Delay in their diagnosis and treatment may significantly increase morbidity and mortality. Causes of esophageal injury include iatrogenic (including esophagogastroduodenoscopy and stent placement), foreign body ingestion, blunt or penetrating trauma to the chest or abdomen, and forceful retching, also called Boerhaave syndrome. Although fluoroscopic esophagography remains the imaging study of choice according the American College of Radiology appropriateness criteria, CT esophagography has been shown to be at least equal to if not superior to fluoroscopic evaluation for esophageal injury. In addition, CT esophagography allows diagnosis of extraesophageal abnormalities, both as the cause of the patient's symptoms as well as incidental findings. CT esophagography also allows rapid diagnosis since the examination can be readily performed in most clinical settings and requires no direct radiologist supervision, requiring only properly trained technologists and a CT scanner. Multiple prior studies have shown the limited utility of fluoroscopic esophagography after a negative chest CT scan and the increase in accuracy after adding oral contrast agent to CT examinations, although there is considerable variability of CT esophagography protocols among institutions. Development of a CT esophagography program, utilizing a well-defined protocol with input from staff from the radiology, gastroenterology, emergency, and general surgery departments, can facilitate more rapid diagnosis and patient care, especially in overnight and emergency settings. The purpose of this article is to familiarize radiologists with CT esophagography techniques and imaging findings of emergent esophageal conditions. Online supplemental material is available for this article. ©RSNA, 2021.
Collapse
Affiliation(s)
- Ashley A Norton-Gregory
- From the Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
| | - Naveen M Kulkarni
- From the Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
| | - Stacy D O'Connor
- From the Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
| | - Joseph J Budovec
- From the Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
| | - Adam P Zorn
- From the Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
| | - Stephane L Desouches
- From the Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226
| |
Collapse
|
2
|
Kulkarni NM, Mannelli L, Zins M, Bhosale PR, Arif-Tiwari H, Brook OR, Hecht EM, Kastrinos F, Wang ZJ, Soloff EV, Tolat PP, Sangster G, Fleming J, Tamm EP, Kambadakone AR. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. Abdom Radiol (NY) 2020; 45:729-742. [PMID: 31768594 DOI: 10.1007/s00261-019-02290-y] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive gastrointestinal malignancy with a poor 5-year survival rate. Its high mortality rate is attributed to its aggressive biology and frequently late presentation. While surgical resection remains the only potentially curative treatment, only 10-20% of patients will present with surgically resectable disease. Over the past several years, development of vascular bypass graft techniques and introduction of neoadjuvant treatment regimens have increased the number of patients who can undergo resection with a curative intent. While the role of conventional imaging in the detection, characterization, and staging of patients with PDAC is well established, its role in monitoring treatment response, particularly following neoadjuvant therapy remains challenging because of the complex anatomic and histological nature of PDAC. Novel morphologic and functional imaging techniques (such as DECT, DW-MRI, and PET/MRI) are being investigated to improve the diagnostic accuracy and the ability to measure response to therapy. There is also a growing interest to detect PDAC and its precursor lesions at an early stage in asymptomatic patients to increase the likelihood of achieving cure. This has led to the development of pancreatic cancer screening programs. This article will review recent updates in imaging techniques and the current status of screening and surveillance of individuals at a high risk of developing PDAC.
Collapse
Affiliation(s)
- Naveen M Kulkarni
- Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA.
| | | | - Marc Zins
- Department of Radiology, Groupe Hospitalier Paris Saint-Joseph, 185 rue Raymond Losserand, 75014, Paris, France
| | - Priya R Bhosale
- Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1473, Houston, TX, 77030-400, USA
| | - Hina Arif-Tiwari
- Department of Medical Imaging, University of Arizona College of Medicine, 1501 N. Campbell Ave, P.O. Box 245067, Tucson, AZ, 85724, USA
| | - Olga R Brook
- Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Shapiro 4, Boston, MA, 02215-5400, USA
| | - Elizabeth M Hecht
- Department of Radiology, Columbia University Medical Center, 622 W 168th St, PH1-317, New York, NY, 10032, USA
| | - Fay Kastrinos
- Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Cancer, 161 Fort Washington Avenue, Suite: 862, New York, NY, 10032, USA
| | - Zhen Jane Wang
- Department of Radiology and Biomedical Imaging, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94143, USA
| | - Erik V Soloff
- Department of Radiology, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA
| | - Parag P Tolat
- Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA
| | - Guillermo Sangster
- Department of Radiology, Ochsner LSU Health Shreveport, 1501 Kings Highway, Shreveport, LA, 71103, USA
| | - Jason Fleming
- Gastrointestinal Oncology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA
| | - Eric P Tamm
- Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1473, Houston, TX, 77030-400, USA
| | - Avinash R Kambadakone
- Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, White 270, Boston, MA, 02114, USA
| |
Collapse
|
3
|
Kulkarni NM, Soloff EV, Tolat PP, Sangster GP, Fleming JB, Brook OR, Wang ZJ, Hecht EM, Zins M, Bhosale PR, Arif-Tiwari H, Mannelli L, Kambadakone AR, Tamm EP. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. Abdom Radiol (NY) 2020; 45:716-728. [PMID: 31748823 DOI: 10.1007/s00261-019-02289-5] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive gastrointestinal malignancy with a poor 5-year survival rate. Accurate staging of PDAC is an important initial step in the development of a stage-specific treatment plan. Different staging systems/consensus statements convened by different societies and academic practices are currently used. The most recent version of the American Joint Committee on Cancer (AJCC) tumor/node/metastases (TNM) staging system for PDAC has shifted its focus from guiding management to assessing prognosis. In order to preoperatively define the resectability of PDAC and to guide management, additional classification systems have been developed. The National Comprehensive Cancer Network (NCCN) guidelines, one of the most commonly used systems, provide recommendations on the management and the determination of resectability for PDAC. The NCCN divides PDAC into three categories of resectability based on tumor-vessel relationship: 'resectable,' 'borderline resectable,' and 'unresectable'. Among these, the borderline disease category is of special interest given its evolution over time and the resulting variations in the definition and the associated recommendations for management between different societies. It is important to be familiar with the evolving criteria, and treatment and follow-up recommendations for PDAC. In this article, the most current AJCC staging (8th edition), NCCN guidelines (version 2.2019-April 9, 2019), and challenges and controversies in borderline resectable PDAC are reviewed.
Collapse
Affiliation(s)
- Naveen M Kulkarni
- Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA.
| | - Erik V Soloff
- Department of Radiology, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA
| | - Parag P Tolat
- Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA
| | - Guillermo P Sangster
- Department of Radiology, LSU Health - Shreveport Ochsner-LSU Health - Shreveport, 1501 Kings Highway, Shreveport, LA, 71103, USA
| | - Jason B Fleming
- Gastrointestinal Oncology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA
| | - Olga R Brook
- Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Shapiro 4, Boston, MA, 02215-5400, USA
| | - Zhen Jane Wang
- Department of Radiology and Biomedical Imaging, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94143, USA
| | - Elizabeth M Hecht
- Department of Radiology, Columbia University Medical Center, 622 W 168th St, PH1-317, New York, NY, 10032, USA
| | - Marc Zins
- Department of Radiology, Groupe Hospitalier Paris Saint-Joseph, 185 Rue Raymond Losserand, 75014, Paris, France
| | - Priya R Bhosale
- Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1473, Houston, TX, 77030-400, USA
| | - Hina Arif-Tiwari
- Department of Radiology, University of Arizona College of Medicine, 1501 N. Campbell Ave., P.O. Box 245067, Tucson, AZ, 85724, USA
| | | | - Avinash R Kambadakone
- Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, White 270, Boston, MA, 02114, USA
| | - Eric P Tamm
- Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1473, Houston, TX, 77030-400, USA
| |
Collapse
|
4
|
Khobragade P, Rupcich F, Fan J, Crotty DJ, Kulkarni NM, O'Connor SD, Foley WD, Schmidt TG. CT automated exposure control using a generalized detectability index. Med Phys 2018; 46:140-151. [PMID: 30417403 DOI: 10.1002/mp.13286] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2018] [Revised: 10/07/2018] [Accepted: 10/26/2018] [Indexed: 12/13/2022] Open
Abstract
PURPOSE Identifying an appropriate tube current setting can be challenging when using iterative reconstruction due to the varying relationship between spatial resolution, contrast, noise, and dose across different algorithms. This study developed and investigated the application of a generalized detectability index ( d gen ' ) to determine the noise parameter to input to existing automated exposure control (AEC) systems to provide consistent image quality (IQ) across different reconstruction approaches. METHODS This study proposes a task-based automated exposure control (AEC) method using a generalized detectability index ( d gen ' ). The proposed method leverages existing AEC methods that are based on a prescribed noise level. The generalized d gen ' metric is calculated using lookup tables of task-based modulation transfer function (MTF) and noise power spectrum (NPS). To generate the lookup tables, the American College of Radiology CT accreditation phantom was scanned on a multidetector CT scanner (Revolution CT, GE Healthcare) at 120 kV and tube current varied manually from 20 to 240 mAs. Images were reconstructed using a reference reconstruction algorithm and four levels of an in-house iterative reconstruction algorithm with different regularization strengths (IR1-IR4). The task-based MTF and NPS were estimated from the measured images to create lookup tables of scaling factors that convert between d gen ' and noise standard deviation. The performance of the proposed d gen ' -AEC method in providing a desired IQ level over a range of iterative reconstruction algorithms was evaluated using the American College of Radiology (ACR) phantom with elliptical shell and using a human reader evaluation on anthropomorphic phantom images. RESULTS The study of the ACR phantom with elliptical shell demonstrated reasonable agreement between the d gen ' predicted by the lookup table and d ' measured in the images, with a mean absolute error of 15% across all dose levels and maximum error of 45% at the lowest dose level with the elliptical shell. For the anthropomorphic phantom study, the mean reader scores for images resulting from the d gen ' -AEC method were 3.3 (reference image), 3.5 (IR1), 3.6 (IR2), 3.5 (IR3), and 2.2 (IR4). When using the d gen ' -AEC method, the observers' IQ scores for the reference reconstruction were statistical equivalent to the scores for IR1, IR2, and IR3 iterative reconstructions (P > 0.35). The d gen ' -AEC method achieved this equivalent IQ at lower dose for the IR scans compared to the reference scans. CONCLUSIONS A novel AEC method, based on a generalized detectability index, was investigated. The proposed method can be used with some existing AEC systems to derive the tube current profile for iterative reconstruction algorithms. The results provide preliminary evidence that the proposed d gen ' -AEC can produce similar IQ across different iterative reconstruction approaches at different dose levels.
Collapse
Affiliation(s)
- P Khobragade
- Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, 53233, USA
| | | | | | | | | | | | | | - Taly Gilat Schmidt
- Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, 53233, USA
| |
Collapse
|
5
|
Ma H, Gros E, Baginski SG, Laste ZR, Kulkarni NM, Okerlund D, Schmidt TG. Automated quantification and evaluation of motion artifact on coronary CT angiography images. Med Phys 2018; 45:5494-5508. [PMID: 30339290 DOI: 10.1002/mp.13243] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2018] [Revised: 09/26/2018] [Accepted: 10/05/2018] [Indexed: 01/13/2023] Open
Abstract
PURPOSE This study developed and validated a Motion Artifact Quantification algorithm to automatically quantify the severity of motion artifacts on coronary computed tomography angiography (CCTA) images. The algorithm was then used to develop a Motion IQ Decision method to automatically identify whether a CCTA dataset is of sufficient diagnostic image quality or requires further correction. METHOD The developed Motion Artifact Quantification algorithm includes steps to identify the right coronary artery (RCA) regions of interest (ROIs), segment vessel and shading artifacts, and to calculate the motion artifact score (MAS) metric. The segmentation algorithms were verified against ground-truth manual segmentations. The segmentation algorithms were also verified by comparing and analyzing the MAS calculated from ground-truth segmentations and the algorithm-generated segmentations. The Motion IQ Decision algorithm first identifies slices with unsatisfactory image quality using a MAS threshold. The algorithm then uses an artifact-length threshold to determine whether the degraded vessel segment is large enough to cause the dataset to be nondiagnostic. An observer study on 30 clinical CCTA datasets was performed to obtain the ground-truth decisions of whether the datasets were of sufficient image quality. A five-fold cross-validation was used to identify the thresholds and to evaluate the Motion IQ Decision algorithm. RESULTS The automated segmentation algorithms in the Motion Artifact Quantification algorithm resulted in Dice coefficients of 0.84 for the segmented vessel regions and 0.75 for the segmented shading artifact regions. The MAS calculated using the automated algorithm was within 10% of the values obtained using ground-truth segmentations. The MAS threshold and artifact-length thresholds were determined by the ROC analysis to be 0.6 and 6.25 mm by all folds. The Motion IQ Decision algorithm demonstrated 100% sensitivity, 66.7% ± 27.9% specificity, and a total accuracy of 86.7% ± 12.5% for identifying datasets in which the RCA required correction. The Motion IQ Decision algorithm demonstrated 91.3% sensitivity, 71.4% specificity, and a total accuracy of 86.7% for identifying CCTA datasets that need correction for any of the three main vessels. CONCLUSION The Motion Artifact Quantification algorithm calculated accurate (<10% error) motion artifact scores using the automated segmentation methods. The developed algorithms demonstrated high sensitivity (91.3%) and specificity (71.4%) in identifying datasets of insufficient image quality. The developed algorithms for automatically quantifying motion artifact severity may be useful for comparing acquisition techniques, improving best-phase selection algorithms, and evaluating motion compensation techniques.
Collapse
Affiliation(s)
- Hongfeng Ma
- Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, 53233, USA
| | - Eric Gros
- GE Healthcare, Waukesha, WI, 53188, USA
| | - Scott G Baginski
- Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA
| | - Zachary R Laste
- Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA
| | - Naveen M Kulkarni
- Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA
| | | | - Taly G Schmidt
- Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, 53233, USA
| |
Collapse
|
6
|
Bhalla M, Aldakkak M, Kulkarni NM, O'Connor SD, Griffin MO, Christians KK, Evans DB, Tsai S, Tolat PP. Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis. Abdom Radiol (NY) 2018; 43:351-363. [PMID: 29185014 DOI: 10.1007/s00261-017-1404-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
BACKGROUND In patients with newly diagnosed pancreatic cancer, the classification of indeterminate liver lesions is an unanswered clinical dilemma as misclassification of these lesions can impact the assignment of clinical stage and subsequent treatment planning. Our objective was to design a standardized classification system to more accurately define the risk of malignancy in indeterminate liver lesions. METHODS In this retrospective study, patients with localized, non-metastatic pancreatic cancer were identified and pre-treatment computed tomography (CT) scans were evaluated for the presence or absence of liver lesions. Liver lesions were defined as definitely benign (1) or indeterminate (2). Indeterminate lesions were further sub-classified as either indeterminate probably benign (2B) or indeterminate possibly malignant (2M). The index liver lesion was evaluated on follow-up imaging for stability or unequivocal disease progression. RESULTS From 2008 to 2015, 304 patients with localized, non-metastatic pancreatic cancer were identified and 125 (41%) patients had liver lesions. Of the 125 patients, the liver lesions in 35 (28%) were classified as definitely benign and in 90 (72%) patients they were classified as indeterminate. The 90 patients with indeterminate lesions included 80 (89%) classified as indeterminate probably benign (2B) and 10 (11%) classified as indeterminate possibly malignant (2M). After a median follow-up of 56 weeks, no patient with a definitely benign lesion had metastatic disease progression of the index lesion. Of the 90 patients with indeterminate liver lesions, the index lesion progressed to unequivocal liver metastasis in 8 (9%) patients; 5 (6%) of the 80 lesions classified as indeterminate probably benign (2B), and 3 (30%) of the ten lesions classified as indeterminate possibly malignant (2M). The sensitivity of the classification system was 38% and the specificity was 91%. The positive predictive value was 30% and the negative predictive value was 94%. CONCLUSIONS A significant proportion of patients with localized pancreatic cancer will have liver lesions identified at the time of diagnosis and most of these lesions will have indeterminate characteristics. A classification system which further stratifies indeterminate liver lesions by malignant potential can assist clinicians in determining optimal treatment plan and is associated with a high negative predictive value.
Collapse
Affiliation(s)
- Manav Bhalla
- Pancreatic Cancer Program, Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA
| | - Mohammed Aldakkak
- Pancreatic Cancer Program, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Naveen M Kulkarni
- Pancreatic Cancer Program, Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA
| | - Stacy D O'Connor
- Pancreatic Cancer Program, Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA
| | - Michael O Griffin
- Pancreatic Cancer Program, Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA
| | - Kathleen K Christians
- Pancreatic Cancer Program, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Douglas B Evans
- Pancreatic Cancer Program, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Susan Tsai
- Pancreatic Cancer Program, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Parag P Tolat
- Pancreatic Cancer Program, Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226, USA.
| |
Collapse
|
7
|
Ma H, Gros E, Szabo A, Baginski SG, Laste ZR, Kulkarni NM, Okerlund D, Schmidt TG. Evaluation of motion artifact metrics for coronary CT angiography. Med Phys 2018; 45:687-702. [PMID: 29222954 DOI: 10.1002/mp.12720] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2017] [Revised: 10/27/2017] [Accepted: 11/26/2017] [Indexed: 01/08/2023] Open
Abstract
PURPOSE This study quantified the performance of coronary artery motion artifact metrics relative to human observer ratings. Motion artifact metrics have been used as part of motion correction and best-phase selection algorithms for Coronary Computed Tomography Angiography (CCTA). However, the lack of ground truth makes it difficult to validate how well the metrics quantify the level of motion artifact. This study investigated five motion artifact metrics, including two novel metrics, using a dynamic phantom, clinical CCTA images, and an observer study that provided ground-truth motion artifact scores from a series of pairwise comparisons. METHOD Five motion artifact metrics were calculated for the coronary artery regions on both phantom and clinical CCTA images: positivity, entropy, normalized circularity, Fold Overlap Ratio (FOR), and Low-Intensity Region Score (LIRS). CT images were acquired of a dynamic cardiac phantom that simulated cardiac motion and contained six iodine-filled vessels of varying diameter and with regions of soft plaque and calcifications. Scans were repeated with different gantry start angles. Images were reconstructed at five phases of the motion cycle. Clinical images were acquired from 14 CCTA exams with patient heart rates ranging from 52 to 82 bpm. The vessel and shading artifacts were manually segmented by three readers and combined to create ground-truth artifact regions. Motion artifact levels were also assessed by readers using a pairwise comparison method to establish a ground-truth reader score. The Kendall's Tau coefficients were calculated to evaluate the statistical agreement in ranking between the motion artifacts metrics and reader scores. Linear regression between the reader scores and the metrics was also performed. RESULTS On phantom images, the Kendall's Tau coefficients of the five motion artifact metrics were 0.50 (normalized circularity), 0.35 (entropy), 0.82 (positivity), 0.77 (FOR), 0.77(LIRS), where higher Kendall's Tau signifies higher agreement. The FOR, LIRS, and transformed positivity (the fourth root of the positivity) were further evaluated in the study of clinical images. The Kendall's Tau coefficients of the selected metrics were 0.59 (FOR), 0.53 (LIRS), and 0.21 (Transformed positivity). In the study of clinical data, a Motion Artifact Score, defined as the product of FOR and LIRS metrics, further improved agreement with reader scores, with a Kendall's Tau coefficient of 0.65. CONCLUSION The metrics of FOR, LIRS, and the product of the two metrics provided the highest agreement in motion artifact ranking when compared to the readers, and the highest linear correlation to the reader scores. The validated motion artifact metrics may be useful for developing and evaluating methods to reduce motion in Coronary Computed Tomography Angiography (CCTA) images.
Collapse
Affiliation(s)
- Hongfeng Ma
- Department of Biomedical Engineering at, Marquette University and Medical College of Wisconsin, Milwaukee, WI, USA
| | | | - Aniko Szabo
- Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Scott G Baginski
- Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Zachary R Laste
- Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Naveen M Kulkarni
- Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, USA
| | | | - Taly G Schmidt
- Department of Biomedical Engineering at, Marquette University and Medical College of Wisconsin, Milwaukee, WI, USA
| |
Collapse
|
8
|
Affiliation(s)
- Amir T Fathi
- From the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (R.P.H.), Massachusetts General Hospital, the Department of Pathology, Brigham and Women's Hospital (F.C.K.), and the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (F.C.K., R.P.H.), Harvard Medical School - all in Boston
| | - Timothy A Graubert
- From the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (R.P.H.), Massachusetts General Hospital, the Department of Pathology, Brigham and Women's Hospital (F.C.K.), and the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (F.C.K., R.P.H.), Harvard Medical School - all in Boston
| | - Naveen M Kulkarni
- From the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (R.P.H.), Massachusetts General Hospital, the Department of Pathology, Brigham and Women's Hospital (F.C.K.), and the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (F.C.K., R.P.H.), Harvard Medical School - all in Boston
| | - Frank C Kuo
- From the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (R.P.H.), Massachusetts General Hospital, the Department of Pathology, Brigham and Women's Hospital (F.C.K.), and the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (F.C.K., R.P.H.), Harvard Medical School - all in Boston
| | - Robert P Hasserjian
- From the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (R.P.H.), Massachusetts General Hospital, the Department of Pathology, Brigham and Women's Hospital (F.C.K.), and the Departments of Medicine (A.T.F., T.A.G.), Radiology (N.M.K.), and Pathology (F.C.K., R.P.H.), Harvard Medical School - all in Boston
| |
Collapse
|
9
|
Abstract
Dual-energy computed tomographic (DECT) technology offers enhanced capabilities that may benefit oncologic imaging in the abdomen. By using two different energies, dual-energy CT allows material decomposition on the basis of energy-dependent attenuation profiles of specific materials. Although image acquisition with dual-energy CT is similar to that with single-energy CT, comprehensive postprocessing is able to generate not only images that are similar to single-energy CT (SECT) images, but a variety of other images, such as virtual unenhanced (VUE), virtual monochromatic (VMC), and material-specific iodine images. An increase in the conspicuity of iodine on low-energy VMC images and material-specific iodine images may aid detection and characterization of tumors. Use of VMC images of a desired energy level (40-140 keV) improves lesion-to-background contrast and the quality of vascular imaging for preoperative planning. Material-specific iodine images enable differentiation of hypoattenuating tumors from hypo- or hyperattenuating cysts and facilitate detection of isoattenuating tumors, such as pancreatic masses and peritoneal disease, thereby defining tumor targets for imaging-guided therapy. Moreover, quantitative iodine mapping may serve as a surrogate biomarker for monitoring effects of the treatment. Dual-energy CT is an innovative imaging technique that enhances the capabilities of CT in evaluating oncology patients.
Collapse
Affiliation(s)
- Mukta D Agrawal
- From the Department of Abdominal and Interventional Radiology, Massachusetts General Hospital, 55 Fruit St, White Building, Room 270, Boston, MA 02114-2696
| | | | | | | | | | | |
Collapse
|
10
|
Fuentes-Orrego JM, Pinho D, Kulkarni NM, Agrawal M, Ghoshhajra BB, Sahani DV. New and Evolving Concepts in CT for Abdominal Vascular Imaging. Radiographics 2014; 34:1363-1384. [DOI: 10.1148/rg.345130070] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023]
|
11
|
Affiliation(s)
- Naveen M Kulkarni
- Massachusetts General Hospital, Division of Abdominal Imaging and Intervention, Boston, MA 02114, USA
| | | | | | | |
Collapse
|
12
|
Kulkarni NM, Uppot RN, Eisner BH, Sahani DV. Response. Radiology 2013; 268:926. [PMID: 24137708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
|
13
|
Pinho DF, Kulkarni NM, Krishnaraj A, Kalva SP, Sahani DV. Initial experience with single-source dual-energy CT abdominal angiography and comparison with single-energy CT angiography: image quality, enhancement, diagnosis and radiation dose. Eur Radiol 2012; 23:351-9. [PMID: 22918562 DOI: 10.1007/s00330-012-2624-x] [Citation(s) in RCA: 94] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2011] [Revised: 06/24/2012] [Accepted: 06/28/2012] [Indexed: 11/29/2022]
Affiliation(s)
- Daniella F Pinho
- Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, 55 Fruit Street, White 270, Boston, MA 02114, USA.
| | | | | | | | | |
Collapse
|
14
|
Kulkarni NM, Uppot RN, Eisner BH, Sahani DV. Radiation dose reduction at multidetector CT with adaptive statistical iterative reconstruction for evaluation of urolithiasis: how low can we go? Radiology 2012; 265:158-66. [PMID: 22891359 DOI: 10.1148/radiol.12112470] [Citation(s) in RCA: 101] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
PURPOSE To evaluate the performance of computed tomographic (CT) examinations at 80 and 100 kV with tube current-time products of 75-150 mA and the effect of adaptive statistical iterative reconstruction (ASIR) on CT image quality in patients with urinary stone disease. MATERIALS AND METHODS In this HIPAA-compliant institutional review board-approved study, verbal consent for prospective low-dose CT and waivers of consent for retrospective review of CT scans were obtained. Between November 2010 and April 2011, 25 patients (15 men, 10 women; mean age, 35 years) with urolithiasis underwent 64-section multidetector CT with 75-150 mA and noise index of 30. Modified protocol was based on body weight (<200 lb [90 kg], 80 kV; >200 lb [90 kg], 100 kV). Images of 5-mm section thickness were reconstructed with filtered back projection (FBP) and 60% and 80% ASIR techniques, with 3-mm coronal and sagittal reformations. Two readers independently reviewed FBP and ASIR data sets for image quality (scale, 1-5), noise (scale , 1-3), and calculi (number, size, location). Confidence levels for urolithiaisis and alternate diagnoses were rated (scale, 1-3). In 13 patients, FBP CT images acquired with the reference standard departmental protocol were available for comparison. Radiation dose was compared between imaging series. Statistical analysis was performed with Wilcoxon signed rank and paired t tests. RESULTS Modified-protocol FBP images showed low image quality (score, 2.5), with improvement on modified-protocol ASIR images (score, 3.4) (P=.03). All 33 stones (mean diameter, 6.1 mm; range, 2-28 mm) at modified-protocol CT were diagnosed by both readers. In 20 of 25 patients (80%), ASIR images were rated adequate for rendering other diagnoses in the abdomen (score, 2.0), as opposed to FBP images (score, 1.3). Mean radiation dose for modified-protocol CT was 1.8 mGy (1.3 mGy for patients<200 lb; 2.3 mGy for patients>200 lb) in comparison with 9.9 mGy for reference-protocol CT (P=.001). CONCLUSION Image quality improvements with ASIR at reduced radiation dose of 1.8 mGy enabled effective evaluation of urinary calculi without substantially affecting diagnostic confidence. © RSNA, 2012.
Collapse
Affiliation(s)
- Naveen M Kulkarni
- Departments of Abdominal Imaging and Intervention and Urology, Massachusetts General Hospital, 55 Fruit St, White 270, Boston, MA 02114
| | | | | | | |
Collapse
|
15
|
Abstract
Fibromatosis colli or pseudotumor of infancy of the sternocleidomastoid muscle is a rare cause of a benign neck mass in neonates and infants. If diagnosed correctly, it can be managed conservatively, and unnecessary investigations can be avoided.
Collapse
Affiliation(s)
- S Smiti
- Department of Radio-diagnosis and Imaging, Kasturba Medical College, Manipal, Karnataka, India
| | | | | |
Collapse
|
16
|
Abstract
BACKGROUND Bifurcational coronary lesions present a major interventional challenge. The differential cutting mechanism of high-speed rotational atherectomy (HSRA) may provide a favourable technique of treating this complex lesion subtype. METHODS We evaluated the use of HSRA (32 lesions) compared to balloon angioplasty (BA) (118 lesions), with provisional stenting in both groups, in a non-randomised, retrospective study of 150 bifurcation-type lesions. RESULTS The HSRA/stent group had a high primary success rate of 97%, an acceptably low in-hospital event rate of 9% and an overall major adverse cardiac event (MACE) rate at a mean follow-up period of 15 +/- 3.4 months of 22.5% with a target lesion revascularisation (TLR) rate of 18.7%. Procedural success in the BA/stent group was 81% with an in-hospital event rate of 14.4%, and the overall MACE rate at follow-up was 27.5% with a TLR rate of 23%. We achieved a greater acute gain in minimal luminal diameter and a lesser percentage of residual stenosis after intervention in the HSRA/stent group compared to the BA/stent group (p < 0.01). Outcome at follow-up favoured the HSRA/stent group, although the difference did not reach statistical significance. CONCLUSION HSRA with provisional stenting provided a safe and effective means of treating bifurcation lesions.
Collapse
Affiliation(s)
- T Nageh
- King's College Hospital, London, UK
| | | | | |
Collapse
|
17
|
Abstract
Coronary spasm is a well-recognized observation during coronary angiography. This report describes a patient who developed spasm of a radial artery bypass graft during coronary intervention. There are many reports on the angiographic follow-up to confirm the surgical results for patency in radial arterial conduits. We share our experience with this first case in the literature noted to have severe vasospasm during PTCA. Cathet. Cardiovasc. Intervent. 47:331-335, 1999.
Collapse
Affiliation(s)
- N M Kulkarni
- Department of Cardiology, King's College Hospital, London, England
| | | |
Collapse
|
18
|
Saxena U, Kulkarni NM, Ferguson E, Newton RS. Lipoprotein lipase-mediated lipolysis of very low density lipoproteins increases monocyte adhesion to aortic endothelial cells. Biochem Biophys Res Commun 1992; 189:1653-8. [PMID: 1482370 DOI: 10.1016/0006-291x(92)90267-o] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Lipoprotein lipase (LPL) bound to vascular endothelial cells hydrolyses triglycerides in plasma lipoproteins. To explore the role of LPL in atherogenesis, the effect of LPL-mediated lipolysis of very low density lipoproteins (VLDL) on monocyte adhesion to endothelial cells was examined. Adhesion of U937 monocytes to porcine aortic endothelial cells that were incubated with VLDL and purified bovine milk LPL was markedly higher than endothelial cells that were incubated with VLDL alone. The increase in monocyte adhesion obtained with VLDL was dependent on the concentration of the lipoprotein, monocyte dose and time of incubation. The increase in adhesion correlated with generation of free fatty acids from the hydrolysis of triglycerides in VLDL by LPL. Furthermore, direct addition of oleic acid to endothelial cells also increased adhesion of monocytes. We postulate that LPL-derived lipolytic products increase monocyte adhesion to vascular endothelium and thereby promote atherogenesis.
Collapse
MESH Headings
- Animals
- Aorta
- Cattle
- Cell Adhesion/drug effects
- Cell Adhesion/physiology
- Cell Line
- Cells, Cultured
- Endothelium, Vascular/physiology
- Fatty Acids, Nonesterified/pharmacology
- Female
- Humans
- Kinetics
- Lipolysis
- Lipoprotein Lipase/metabolism
- Lipoproteins/blood
- Lipoproteins/isolation & purification
- Lipoproteins/pharmacology
- Lipoproteins, HDL/blood
- Lipoproteins, HDL/isolation & purification
- Lipoproteins, HDL/pharmacology
- Lipoproteins, LDL/blood
- Lipoproteins, LDL/isolation & purification
- Lipoproteins, LDL/pharmacology
- Lipoproteins, VLDL/blood
- Lipoproteins, VLDL/isolation & purification
- Lipoproteins, VLDL/pharmacology
- Milk/enzymology
- Monocytes/physiology
- Oleic Acid
- Oleic Acids/pharmacology
- Swine
Collapse
Affiliation(s)
- U Saxena
- Department of Pharmacology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI 48105
| | | | | | | |
Collapse
|